Ribovate Therapeutics

Ribovate is developing the next generation targeted mRNA-lipid nanoparticle therapeutic platform.

Startup Details

Co-Founded by: Drew Weissman and Hamideh Parhiz

Participates in PCI Ventures UPstart

Sesen Bio and Carisma Therapeutics Announce Merger Agreement

Penn Medicine to Conduct New Clinical Trial to Evaluate Safety and Efficacy of Chewing Gum Designed by School of Dental Medicine Researchers to Trap SARS-CoV-2 in Saliva

PCI Startup Vital Start Health Wins 2022 Citizens Small Business Community Champions Award for their Work in Neonatal Care

President’s Innovation Prize Winner Lumify Care and PCI Startup Neuralert Hit Major Milestones in 2022



Skip to content